Compare Mutual Funds

Pros

-

5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Cons

-

-

INDMoney rank
-
1/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

4 Years 4 Months

7 Years 9 Months

Fund AUM

₹210 Cr

₹6658 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.47%

1.02%

Exit Load

0.5%

1%

Benchmark Index

Nifty Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

42

44

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(10.76%)
  2. Divi's Laboratories Ltd(8.96%)
  3. Apollo Hospitals Enterprise Ltd(6.21%)
  4. Max Healthcare Institute Ltd Ordinary Shares(5.49%)
  5. Torrent Pharmaceuticals Ltd(4.98%)
  1. Sun Pharmaceuticals Industries Ltd(11.2%)
  2. Cipla Ltd(9.43%)
  3. Dr Reddy's Laboratories Ltd(7.27%)
  4. Mankind Pharma Ltd(6.34%)
  5. Divi's Laboratories Ltd(6.22%)
No of Sectors

4

2

Top 3 Sectors
  1. Health(95.07%)
  2. Basic Materials(2.58%)
  3. Financial Services(1.43%)
  1. Health(98.89%)
  2. Basic Materials(1.11%)
Equity %

98.23%

97.6%

Debt %

-

-

P/E

40.47

31.1

P/B

5.37

3.84

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

5.63%

0.64%

3-Month Return

-2.29%

-5.41%

6-Month Return

-2.97%

-4.62%

1-Year Return

5.65%

8.9%

3-Year Return

22.96%

28.2%

5-Year Return

-

17.97%

Sharpe

0.99

1.3

Alpha

-1.28

2.27

Beta

0.91

0.94

Standard Deviation

15.98

15.86

Information Ratio

-0.69

0.44

Description

ITI Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Rohan Korde, Dhimant Shah

Dharmesh Kakkad, Sharmila D’mello

Most Popular Comparisons